Checkpoint responses in cancer therapy /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Totowa, N.J. :
Humana,
[2008]
|
| Series: | Cancer drug discovery and development.
|
| Subjects: |
Table of Contents:
- RB-pathway : cell cycle control and cancer therapy
- Targeting the p53/MDM2 pathway for cancer therapy
- DNA topoisomerases as targets for the chemotherapeutic treatment of cancer
- Targeting ATM/ATR in the DNA damage checkpoint
- Compounds that abrogate the G2 checkpoint
- CDK inhibitors as anticancer agents
- CHFR as a potential anticancer target
- Antimicrotubule agents
- Kinesin motor inhibitors as effective anticancer drugs
- Targeting the spindle checkpoint in cancer chemotherapy
- Antiproliferation inhibitors targeting aurora kinases
- Plks as novel targets for cancer drug design
- Do histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?